Table 2.
Medication | Dose | Notes | ||
---|---|---|---|---|
Inhibition of hormone synthesis | ||||
Propylthiouracil (PTU) | 600 mg loading dose, followed by 200–250 mg PO q4–6h | Additional inhibition of peripheral deiodination However, recent warning from FDA regarding severe liver toxicity with PTU makes either carbimazole or methimazole first-choice thionamide | ||
Carbimazole (or methimazole) | 20–30 mg PO q4–6h | |||
Inhibition of hormone release | ||||
SSKI (Potassium Iodide) | 5 drops PO q6–8h | Administer at least 1 hour after thionamide | ||
Lugol's Solution | 5–10 drops PO q6–8h In UK, 1 ml PO q6h | Administer at least 1 hour after thionamide | ||
Iapanoic Acid | 1000 mg IV q8h for 24 h, followed by 500 mg bd | Administer at least 1 hour after thionamide, infrequently available | ||
Inhibition of peripheral effects of excess thyroid hormone | ||||
Propranolol | 1–2 mg/min IV q15min up to max 10 mg 40–80 mg PO q4–6h | IV dose initially if haemodynamically unstable | ||
Esmolol | 50 μg/kg/min IV—may increase by 50 μg/kg/min q4min as required to a max of 300 μg/kg/min. | Short acting | ||
Metoprolol | 100 mg PO q6h | Cardioselective; use if known airways disease | ||
Diltiazem | 60–90 mg PO q6–8h | Use if beta-blockers contraindicated IV formulation available | ||
Supplementary management | ||||
Hydrocortisone | 100 mg IV q6h | |||
Dexamethasone | 2 mg IV q6h | |||
Acetaminophen (commonly known as paracetamol or Tylenol) | 1 g PO q6h | Care if significant hepatic dysfunction | ||
Additional therapies | ||||
Lithium Carbonate | 300 mg PO q8h | Monitor for toxicity | ||
Potassium perchlorate | 1 g PO od | Associated with aplastic anaemia and nephritic syndrome | ||
Cholestyramine | 4g PO q6–12h |
PO, oral; IV, intravenous; q4–6h, every 4–6 hours; q6h, every 6 hours; q8h, every 8 hours; q4min, every 4 minutes; q15min, every 15 minutes; od, once daily; bd, twice daily.